U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07349823) titled 'Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection' on Jan. 05.
Brief Summary: The exact etiology and pathogenesis of immune related diseases (such as autoimmune hepatitis, systemic lupus erythematosus, etc.) have not been fully elucidated, and are generally believed to be the result of multiple factors such as genetics, environment, and immune regulation abnormalities. The current standard treatment for immune related diseases includes corticosteroids, biologics (such as belimumab, rituximab), and immunosuppressants (such as mycophenolate mofetil, azathioprine, cyclophospha...